Julie A. Cox

2.0k citations

20 papers · 650 indexed · h-index 13

Co-authors: Paul A. White John C. Bell Jean‐Simon Diallo Fabrice Le Bœuf Theresa Falls Mick D. Fellows Gary Gronseth Markus Vähä‐Koskela
Topics: Carcinogens and Genotoxicity Assessment (8 papers)Virus-based gene therapy research (4 papers)interferon and immune responses (3 papers)
Cited by: Genetics Oncology Immunology
Journals: Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: Canada United States Netherlands

In The Last Decade

Julie A. Cox

19 papers receiving 642 citations

Peers

Countries citing papers authored by Julie A. Cox

Since Specialization

Citations

This map shows the geographic impact of Julie A. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Cox more than expected).

Fields of papers citing papers by Julie A. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Cox. The network helps show where Julie A. Cox may publish in the future.

Co-authorship network of co-authors of Julie A. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Cox. A scholar is included among the top collaborators of Julie A. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Cox. Julie A. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rail suicide: A systematic review using systems thinking 2025 ·Safety Science ·Gemma J. M. Read,(unknown),Anjum Naweed,Julie A. Cox,Lay San Too,Daniel F. Hermens,Rod McClure,Paul M. Salmon	0
2	Application of a new approach methodology (NAM)-based strategy for genotoxicity assessment of data-poor compounds 2023 ·SHILAP Revista de lepidopterología ·(unknown),Alexandra S. Long,Andrew Williams,Matthew J. Meier,Julie A. Cox,(unknown),Carole L. Yauk,Paul A. White	18
3	In vitro mutagenicity of selected environmental carcinogens and their metabolites in MutaMouse FE1 lung epithelial cells 2020 ·Mutagenesis ·(unknown),(unknown),Julie A. Cox,Alexandra S. Long,Nikolai L. Chepelev,David H. Phillips,Paul A. White,Volker M. Arlt	4
4	In vitro mammalian cell mutation assays based on transgenic reporters: A report of the International Workshop on Genotoxicity Testing (IWGT) 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Paul A. White,Mirjam Luijten,Masayuki Mishima,Julie A. Cox,(unknown),Rebecca M. Maertens,Edwin Zwart	21
5	The mutagenic activity of select azo compounds in MutaMouse target tissues in vivo and primary hepatocytes in vitro 2019 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Julie A. Cox,Paul A. White	16
6	The development and prevalidation of anin vitromutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicals 2019 ·Environmental and Molecular Mutagenesis ·Julie A. Cox,Edwin Zwart,Mirjam Luijten,Paul A. White	6
7	Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis 2019 ·Neurology ·Mauricio Farez,Jorge Correale,Melissa J. Armstrong,Alexander Rae‐Grant,David Gloss,Diane Donley,Yolanda Holler‐Managan,Norman J. Kachuck,Douglas Jeffery,(unknown),Gary Gronseth,David Michelson,(unknown),Julie A. Cox,(unknown),James J. Sejvar,Pushpa Narayanaswami	105
8	The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part I: Isolation, structural, genetic, and biochemical characterization 2018 ·Environmental and Molecular Mutagenesis ·Julie A. Cox,Edwin Zwart,Mirjam Luijten,Paul A. White	4
9	Evaluation of the LacZ reporter assay in cryopreserved primary hepatocytes for In vitro genotoxicity testing 2016 ·Environmental and Molecular Mutagenesis ·Mirjam Luijten,Edwin Zwart,Martijn E.T. Dollé,(unknown),Julie A. Cox,Paul A. White,Jan van Benthem	6
10	Mouthguard Use and Awareness of Junior Rugby League Players in the Gold Coast, Australia 2015 ·Clinical Journal of Sport Medicine ·Jeroen Kroon,Julie A. Cox,(unknown),(unknown),William Kong	17
11	Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase 2015 ·Cell Death Discovery ·(unknown),Philip A. Harris,Rakesh Nagilla,Viera Kasparcova,Sandra C. Hoffman,Brandon Swift,Lauren Dare,Michelle C. Schaeffer,Carol A. Capriotti,Michael T. Ouellette,(unknown),David D. Wisnoski,Julie A. Cox,Michael Reilly,(unknown),John Bertin,(unknown)	115
12	The utility of metabolic activation mixtures containing human hepatic post-mitochondrial supernatant (S9) forin vitrogenetic toxicity assessment 2015 ·Mutagenesis ·Julie A. Cox,Mick D. Fellows,(unknown),Paul A. White	47
13	Evidence-based guideline summary: Evaluation, diagnosis, and management of congenital muscular dystrophy 2015 ·Neurology ·Peter B. Kang,Leslie Morrison,Susan T. Iannaccone,Robert J. Graham,Carsten G. Bönnemann,Anne Rutkowski,Joseph E. Hornyak,Ching H. Wang,Kathryn N. North,Maryam Oskoui,Thomas S.D. Getchius,Julie A. Cox,(unknown),Gary Gronseth,Robert C. Griggs	68
14	Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model 2014 ·Gene Therapy ·Janne Ruotsalainen,Minna U. Kaikkonen,Minna Niittykoski,Miika Martikainen,Chantal G. Lemay,Julie A. Cox,(unknown),(unknown),Theresa Falls,Jean‐Simon Diallo,Fabrice Le Bœuf,John C. Bell,Seppo Ylä‐Herttuala,Ari Hinkkanen,Markus Vähä‐Koskela	30
15	Model-based rational design of an oncolytic virus with improved therapeutic potential 2013 ·Nature Communications ·Fabrice Le Bœuf,Cory Batenchuk,Markus Vähä‐Koskela,Sophie Breton,Dominic G. Roy,Chantal G. Lemay,Julie A. Cox,Hesham Abdelbary,Theresa Falls,(unknown),Harold Atkins,David F. Stojdl,Jean‐Simon Diallo,Mads Kærn,John C. Bell	35
16	Resistance to Two Heterologous Neurotropic Oncolytic Viruses, Semliki Forest Virus and Vaccinia Virus, in Experimental Glioma 2012 ·Journal of Virology ·Markus Vähä‐Koskela,Fabrice Le Bœuf,Chantal G. Lemay,Naomi De Silva,Jean‐Simon Diallo,Julie A. Cox,(unknown),(unknown),Abhirami A. Ananth,(unknown),Sophie Breton,Dominic G. Roy,Theresa Falls,J Brun,Akseli Hemminki,Ari Hinkkanen,John C. Bell	17
17	Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors 2010 ·PLoS ONE ·(unknown),Jean‐Simon Diallo,(unknown),Marianne M. Stanford,Fabrice Le Bœuf,Naomi De Silva,Julie A. Cox,(unknown),(unknown),Theresa Falls,J. Andrea McCart,Harry Atkins,Caroline J. Breitbach,David H. Kirn,Stephen H. Thorne,John C. Bell	60
18	A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers 2010 ·Molecular Therapy ·Jean‐Simon Diallo,Fabrice Le Bœuf,(unknown),Julie A. Cox,Markus Vähä‐Koskela,Hesham Abdelbary,(unknown),(unknown),Theresa Falls,Jenny Wang,(unknown),Jan Blanchard,Eric D. Brown,David H. Kirn,John Hiscott,Harry Atkins,Brian D. Lichty,John C. Bell	78
19	Nonmyeloablative Matched Unrelated Donor Hematopoietic Cell Transplant for Late-Onset Omenn's with Novel RAG Mutation 2007 ·Journal of Allergy and Clinical Immunology ·(unknown),Julie A. Cox,Irene Rainville,R.P. Nelson,M. Teresa de la Morena	1
20	Negative staining can cause clumping of Bordetella pertussis fimbriae 1994 ·Micron ·Ross Hamilton,Jillian Bennet,Debbie Drane,(unknown),(unknown),Ana Stefančić,Julie A. Cox	2

About Julie A. Cox

Julie A. Cox is a scholar working on Cancer Research, Emergency Medical Services and Microbiology, having authored 20 papers that have together received 650 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (8 papers), Virus-based gene therapy research (4 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Genetics (207 citations), Oncology (175 citations) and Immunology (113 citations). Julie A. Cox has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Paul A. White, John C. Bell, Jean‐Simon Diallo, Fabrice Le Bœuf, Theresa Falls, Mick D. Fellows, Gary Gronseth, Markus Vähä‐Koskela, David H. Kirn and Harry Atkins. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact